Summary
Although often not considered, the heart is one of the targets of multiple organ failure in sepsis and septic shock, with myocardial depression being a prominent component of this “acute septic cardiomyopathy”. Hypotheses concerning the etiology of this depression are increasingly elucidated on a cellular level, including dysfunction of the β-adrenoceptor/G protein/adenylate cyclase system, calcium channel blockade by cardiodepressant factor, contractile impairment by activated leucocytes, as well as inhibition of protein synthesis by Pseudomonas exotoxin A.
In the search for “mechanisms of myocardial depression in sepsis”, isolated cardiomyocytes may play a role as research tools with respect to: a) discrimination between direct and indirect cardiodepressant effects; b) identifying not only the acute, but also chronic toxin- and mediator-induced cardiodepression; c) clarification of the mechanism of action of cardiodepressant bacterial toxins and sepsis mediators; d) establishment of in vitro models of leucocyte-mediated cardiodepressann in sepsis.
References
Abel FL (1989) Myocardial function in sepsis and endotoxin shock. Am J Physiol 257:R1265-R1281
Bender B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871
Bristow MR, Port JD, Sandoval AB, Rasmussen R, Ginsburg R, Feldman AM (1989) β-adrenergic receptor pathways in the failing human heart. Heart Failure 5:77–90
Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP and the Swiss-Dutch J5 Immunoglobulin Study Group (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Disease 161:982–987
Carli A, Auclair M-C (1983) Role of humoral cardiodepressant factors in septic shock — A brief review. In: Lewis DH, Haglund U (eds) Shock Research. Elsevier Science Publishers BV, pp 203–214
Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG (1990) Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes — Impairment of signal transduction. Circulation Research 67:753–763
Conrad SA, Finkelstein JL, Madden MR, Burk J, Goodwin CW (1990) Cardiovascular dysfunction in multiple organ failure. In: Deitch EA (ed) Multiple Organ Failure — Pathophysiology and Basic Concepts of Therapy. Thieme Inc, New York Stuttgart, pp 172–191
Cross AS, Sadoff JC, Iglewski BH, Sokol PA (1980) Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans. J Infect Dis 142:538–546
Danner RL, Natanson C, Elin RJ, Hosseini JM, Banks S, MacVittie TJ, Parrillo JE (1990) Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 98:1480–1487
Entman ML, Youker K, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW (1990) Neutrophil adherence to isolated adult canine myocytes — evidence for a CD18-dependent mechanism. J Clin Invest 85:1497–1506
Fuji H, Kuzuya T, Hoshida S, Nishida M, Kim Y, Goshima K, Tada M (1988) Free radicals derived from neutrophils mediate reoxygenation-induced myocardial injury. Circulation Supplement II 78:11–56
Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753–6757
Hallström S, Vogl C, Redl H, Schlag G (1990) Net inotropic plasma activity in canine hypovolemic traumatic shock: low molecular weight plasma fraction after prolonged hypotension depresses cardiac muscle performance in vitro. Circ Shock 30:129–144
Hallström S, Koidl B, Müller U, Werdan K, Schlag G (1991) A cardiodepressant factor isolated from blood blocks Ca2+ current in cardiomyocytes. Am J Physiol 260:H 869-H 876
Hegewisch S, Weh JH, Hossfeld DK (1990) TNF-induced cardiomyopathy. Lancet I:294–295
Isner JM, Dietz WA (1988) Cardiovascular consequences of recombinant DNA technology: Interleukin-2. Ann Int Med 109:933–935
Kaneko M, Chapman DC, Ganguly PK, Beamish RE, Dhalla NS (1991) Modification of cardiac adrenergic receptors by oxygen free radicals. Am J Physiol 260:H821-H826
Lefer AM (1983) Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock. Molecular and Cellular Aspects of Shock and Trauma. Alan R Liss Inc, pp 111–123
Mak IT, Kramer JH, Freedman AM, Tse SYH, Weglicki WB (1990) Oxygen radical-mediated injury of myocytes — protection by propranolol. J Mol Cell Cardiol 22:687–695
Massey KD, Burton K (1990) Free radical damage in neonatal rat cardiac myocyte cultures: effects of α-tocopherol, trolox, and phytol. Free Radical Biology & Medicine 8:449–458
Michie HR, Nanogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486
Müller U, Werdan K (1990) Pseudomonas exotoxin A inhibits protein biosynthesis in neonatal rat heart muscle cells and modifies the inotropic state of these cells. J Mol Cell Cardiol 22 Suppl III:S 26
Müller U, Pfeifer A, Reng R, Rupp H, Werdan K (1991) Impairment of the contractile state of cardiomyocytes by Pseudomonas exotoxin A. Circulatory Shock 34:Abstracts 17
Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE (1989) Role of endotoxemia in cardiovascular dysfunction and mortality. J Clin Invest 83:243–251
Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo CG, Banks SM, MacVittie TJ, Parrillo JE (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169:823–832
Pardini BJ, Jones SB, Filkins JP (1982) Contribution of depressed uptake to the depletion of norepinephrine from rat heart and spleen during endotoxin shock. Circulatory Shock 9:129–143
Parrillo JE (1989) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40:469–485
Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990) Septic shock in humans — Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of Internal Medicine 113:227–242
Pilati CF, Clark RS, Gilloteaux J, Bosso FJ, Holcomb P, Maron MB (1990) Excessive sympathetic nervous system activity decreases myocardial contractility. Proc Soc Exp Biol Med 193:225–231
Pilz G, Class 1, Boekstegers P, Pfeifer A, Müller U, Werdan K (in press) Pseudomonas immunoglobulin therapy in patients with Pseudomonas sepsis and septic shock. In: Schönfeld H (ed) Antibiotics and Chemotherapy Vol XX: Pseudomonas aeruginosa Infection (Döring G et al, eds). Basel, Karger Inc
Pollack M, Young LS (1979) Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest 63:276–286
Reithmann C, Werdan K (1989) Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure. Naunyn-Schmiedeberg's Arch Pharmacol 339:138–144
Reithmann C, Gierschik P, Sidiropoulos D, Werdan K, Jakobs KH (1989) Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunits. Europ J Pharmacol — Mol Pharmacol Section 172:211–221
Reithmann C, Gierschik P, Müller U, Werdan K, Jakobs KH (1990) Pseudomonas exotoxin A prevents β-adrenoceptor-induced up-regulation of Gi protein α-subunits and adenylate cyclase desensitization in rat heart muscle cells. Molecular Pharmacology 37:631–638
Reithmann C, Gierschik P, Werdan K, Jakobs KH (1991) Tumor necrosis factor α up-regulates Giα and Gβ proteins and adenylate cyclase responsiveness in rat cardiomyocytes. Europ J Pharmacol — Mol Pharmacol Section 206:53–60
Sagher U, Rosen H, Sarel O, Becker Y (1986) Studies on a pancreatic cardiodepressant factor. Circulatory Shock 19:319–327
Sardesai SH, Mourant AJ, Sivathandon Y, Farrow B, Gibbons DO (1990) Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 63:234–237
Schirmer WJ, Schirmer JM, Fry DE (1989) Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 124:445–448
Schuchter LM, Hendricks CB, Holland KH, Shelton BK, Hutchins GM, Baughman KL, Ettinger DS (1990) Eosinophilic myocarditis associated with high-dose interleukin-2 therapy. Am J Med 88:439–440
Schuster HP (1989) Schlußfolgerungen. In: Werdan K (ed) Sepsis: Toxinwirkung, Herzschädigung, Quantifizierung, supportive Therapie mit Immunglobulinen. Intensivmed 26 Suppl 1:S152–S153
Semb AG, Vaage J, Mjos OD (1990) Oxygen free radical producing leucocytes cause functional depression of isolated rat hearts: role of leukotrienes. J Mol Cell Cardiol 22:555–563
Snell K, Holder IA, Leppla SA, Saelinger CB (1978) Role of exotoxin and protease virulence factors in experimental infections with Pseudomonas aeruginosa. Infection and Immunity 19:839–884
Snell RJ, Parrillo JE (1991) Cardiovascular dysfunction in septic shock. Chest 99:1000–1009
Sonnenblick M, Rosenmann D, Rosin A (1990) Reversible cardiomyopathy induced by interferon. Brit Med J 300:1174–1175
Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Eng] J Med 321:280–287
Tracey KJ, Fong Y, Hesse DG, Monongue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662–664
Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355–357
Wagenknecht B, Hug M, Freudenrich C, Hallström S, Hübner G, Lieberman M, Schlag G, Werdan K (1990) Cardiodepressive and cardiotoxic effects of oxygen free radicals in cultured heart muscle cells. J Mol Cell Cardiol 22 (Supplement III):S51
Wagenknecht B, Hug M, Hübner G, Werdan K (1990) Does superoxide dismutase protect heart muscle cells against oxygen free radicals? Eur Heart J 11 (Abstract Supplement):136
Weitzberg E, Lundberg JM, Rudehill A (1991) Elevated plasma levels of endothelin in patients with sepsis syndrome. Circulatory Shock 33:222–227
Werdan K, Melnitzki SM, Pilz G, Kapsner T (1989) The cultured rat heart cell: a model to study direct cardiotoxic effects of Pseudomonas endo- and exotoxins. In: Schlag G, Redl H (eds) Second Vienna Shock Forum; Progress in Clinical and Biological Research Volume 308. Alan R Liss Inc, New York, pp 247–251
Werdan K, Erdmann E (1989) Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity. In: Fleischer S, Fleischer B (eds) Methods in Enzymology Vol 173. Biomembranes Part T Cellular and Subcellular Transport: Eukaryotic (Nonepithelial) Cells. Academic Press Inc, San Diego New York, pp 634–662
Woodley SL, McMillan M, Shelby J, Lynch DH, Roberts LK, Ensley RD, Barry WH (1991) Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation 83:1410–1418
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. G. Riecker on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Werdan, K., Müller, U., Reithmann, C. et al. Mechanisms in acute septic cardiomyopathy: Evidence from isolated myocytes. Basic Res Cardiol 86, 411–421 (1991). https://doi.org/10.1007/BF02190709
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02190709